Jan 8, 2014 by Gaurab ChakrabartiWith Phase II Success, Amgen's Romosozumab Beats Standard of Care TreatmentRomosozumab could be Amgen's megablockbuster.
Jan 6, 2014 by Gaurab ChakrabartiVertex's VX-765 holds promise for HIV treatmentVertex might have a first-in-class HIV therapy on their hands.
